Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management
Transplant International · 02.10.2024 · 37
DOI: 10.3389/ti.2024.12803 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 02.10.2024. Verfasst von Paolo A Grossi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy. Hauptthemen laut MEDLINE: COVID-19, Tissue Donors. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Expected and unexpected donor-derived infections are a rare complication of solid organ transplantation, but can result in significant morbidity and mortality. Over the last years, the growing gap existing between patients on the waiting list and available organs has favored the use of organs from donors with suspected or confirmed infections, thanks to the improvement of risk mitigation strategies against transmission of well recognized and emerging infections. Given the recent developments, the particular interest of this review is to summarize data on how to maximize utilization of HIV+ donors in HIV+ recipients, the use of HCV-viremic donors and HBV positive donors. This article also covers the implications for recipient of organs from donors with bacteremia and the challenge of multidrug resistant (MDR) infections. Lastly this review describes emerging risks associated with recent Coronavirus Disease-2019 (COVID-19) pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
- Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, United States.
Zitieren
APA
Grossi, P. A., Wolfe, C., & Peghin, M. (2024). Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management. Transplant International, 37. https://doi.org/10.3389/ti.2024.12803
Vancouver
Grossi PA, Wolfe C, Peghin M. Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management. Transplant International. 2024;37. doi:10.3389/ti.2024.12803
BibTeX
@article{Grossi2024,
author = {Grossi, Paolo A and Wolfe, Cameron and Peghin, Maddalena},
title = {Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management},
journal = {Transplant International},
year = {2024},
volume = {37},
doi = {10.3389/ti.2024.12803}
}
EUVIMED